Roger Crystal
Director/Board Member chez MIND MEDICINE (MINDMED)
Fortune : 50 401 $ au 29/02/2024
Profil
Roger Crystal is on the board of Biotechnology Innovation Organization and Mind Medicine (MindMed), Inc. and Member of Santa Monica Bay Chapter and Member of YPO Santa Monica Bay Chapter.
Dr. Crystal previously occupied the position of Chief Business Officer of ImaginAb, Inc. and Chief Executive Officer & Director at Opiant Pharmaceuticals, Inc.
He received an MBA from London Business School and a doctorate and an undergraduate degree from the University of Birmingham.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
26/12/2023 | 8 819 ( 0,01% ) | 50 401 $ | 29/02/2024 |
Postes actifs de Roger Crystal
Sociétés | Poste | Début |
---|---|---|
MIND MEDICINE (MINDMED) | Director/Board Member | 11/08/2022 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
YPO Santa Monica Bay Chapter | Corporate Officer/Principal | - |
Santa Monica Bay Chapter
Santa Monica Bay Chapter Miscellaneous Commercial ServicesCommercial Services Santa Monica Bay Chapter provides social services. The private company is based in Fresno, CA. | Corporate Officer/Principal | - |
Anciens postes connus de Roger Crystal
Sociétés | Poste | Fin |
---|---|---|
OPIANT PHARMACEUTICALS, INC. | Chief Executive Officer | 02/03/2023 |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Corporate Officer/Principal | 01/02/2016 |
Formation de Roger Crystal
University of Birmingham | Doctorate Degree |
London Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MIND MEDICINE (MINDMED) | Health Technology |
Entreprise privées | 5 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Santa Monica Bay Chapter
Santa Monica Bay Chapter Miscellaneous Commercial ServicesCommercial Services Santa Monica Bay Chapter provides social services. The private company is based in Fresno, CA. | Commercial Services |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
YPO Santa Monica Bay Chapter |